The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Alekseeva A.I.

Avtsyn Research Institute of Human Morphology;
Institute of Higher Nervous Activity and Neurophysiology

Kudelkina V.V.

Avtsyn Research Institute of Human Morphology

Kosyreva A.M.

Avtsyn Research Institute of Human Morphology

Drozd S.F.

Burdenko Neurosurgical Center

Gelperina S.E.

Mendeleev National University of Chemical Technology

Pavlova G.V.

Burdenko National Medical Research Center of Neurosurgery

Khalansky A.S.

Avtsyn Research Institute of Human Morphology

Nitric oxide donor nitrosorbide potentiates the antitumor effect of doxorubicin against experimental glioblastoma

Authors:

Alekseeva A.I., Kudelkina V.V., Kosyreva A.M., Drozd S.F., Gelperina S.E., Pavlova G.V., Khalansky A.S.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2022;86(1): 66‑73

Views: 1780

Downloaded: 39


To cite this article:

Alekseeva AI, Kudelkina VV, Kosyreva AM, Drozd SF, Gelperina SE, Pavlova GV, Khalansky AS. Nitric oxide donor nitrosorbide potentiates the antitumor effect of doxorubicin against experimental glioblastoma. Burdenko's Journal of Neurosurgery. 2022;86(1):66‑73. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20228601166

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.